Home Search

bioprinting - search results

If you're not happy with the results, please do another search

BASF and Poietis sign an agreement on 3D bioprinting

BASF and Poietis have announced the signature of a framework agreement on further development and services in the field of 3D bioprinting technology.

Inserm launches ART for 3D Bioprinting in Bordeaux

The creation of accelerators of technological research (ART) is a priority of Inserm’s strategic plan.
Dr. Luciano Paulino da Silva

3D bioprinting to be tested in agricultural research

In the Laboratory of Nanobiotechnology (LNANO) of Embrapa Genetic Resources and Biotechnology, in Brasília, DF (Brazil) mimicking nature and manufacturing leaves, seeds and even more complex structures – of animals, plants, or microorganisms – could soon become reality.

Organovo collabs with UOV in developing bioprinting for VML

Organovo Holdings, Inc., a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, has announced a collaboration with the University of Virginia to develop 3D bioprinted tissues for volumetric muscle loss (“VML”) injury.

3D Systems collab with United Therapeutics for Bioprinting

3D Systems and United Therapeutics Corporation have announced plans to develop solid-organ scaffolds for human transplants.
Scientist Mr. Yujian Kang

3D bioprinting blood vessels – no monkey business

Stem cell biotechnology has experienced a breakthrough with the successful implant of 3D printed blood vessels in monkeys. On December 11th, a press conference was given in Chengdu, China, by Dr Y. James Kang.

3D BIOPRINTING CONFERENCE

The 4th edition of the 3D Bioprinting Conference will take place on January 31, 2017, at MECC Maastricht, The Netherlands. The conference is of interest...

URSC enters agreement with 3D Bioprinting

URSC (Unified Rocket and Space Corporation, a member of ROSCOSMOS State Corporation) has recently entered into a cooperation agreement with 3D Bioprinting Solutions.

Bioprinting technique creates 3D tissue

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School for Engineering and Applied Sciences (SEAS) has recently invented a method for 3D bioprinting thick vascularized tissue constructs composed of human stem cells, extracellular matrix, and circulatory channels lined with endothelial blood vessel cells.

New way 3D bioprinting with acoustic tweezers

Researchers from Carnegie Mellon University President Subra Suresh and collaborators Tony Jun Huang from the Pennsylvania State University and Ming Dao from MIT, have demonstrated that acoustic tweezers can be used to non-invasively move and manipulate single cells along three dimensions, providing new method for 3D bioprinting.
Your questions answered: 3d bioprinting

Your questions answered: 3d bioprinting

Experts answer your questions on the emerging field of 3D bioprinting. While 3D printing becomes more established within  the manufacturing sector, one of its most...
3dfabprintmedica2017

Conference on Additive Manufacturing for medical applications

Medical is one of the fastest growing application areas of 3D printing / Additive Manufacturing. After a very successful first 3D fab+print Seminar at MEDICA / COMPAMED in 2017, this year Additive Manufacturing will again be addressed at the yearly international trade fair for medical professionals in Düsseldorf, Germany.
Call for Presentations - 3D fab+print Conference at MEDICA / COMPAMED 2018

Call for Presentations – 3D fab+print Conference at MEDICA / COMPAMED 2018

Medical is one of the fastest growing application areas of 3D printing / Additive Manufacturing. After a very successful first 3D fab+print Seminar at MEDICA / COMPAMED in 2017, this year Additive Manufacturing will again be addressed at the yearly international trade fair for medical professionals in Düsseldorf, Germany.

Genome BC invests USD 1 M in Aspect Biosystems

Genome BC is pleased to announce USD 1 M in funding to Aspect Biosystems (Aspect), a privately held biotechnology company focused on commercializing cutting-edge 3D bioprinting technologies.

BIOLIFE4D launches Regulation A+ for organ replacement

BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, has announced that it has launched a Regulation A+ (Mini-IPO) following the validation of its Form 1-A offering circular by the U.S. Securities and Exchange Commission.